Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
+2.41M
-
Total reported value, excl. options
-
$1.91B
-
Value change
-
+$178M
-
Put/Call ratio
-
1.05
-
Number of buys
-
105
-
Number of sells
-
-68
-
Price
-
$72.33
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q1 2018
224 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2018.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
of 207M outstanding shares and own 12.76% of the company stock.
Largest 10 shareholders include Meditor Group Ltd (2.59M shares), BB BIOTECH AG (2.41M shares), Pentwater Capital Management LP (2.31M shares), FMR LLC (1.73M shares), BlackRock Inc. (1.49M shares), VANGUARD GROUP INC (1.49M shares), STATE STREET CORP (1.31M shares), Partner Fund Management, L.P. (1.13M shares), CREDIT SUISSE AG/ (1.08M shares), and Boxer Capital, LLC (900K shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.